Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Linezolid for Multi-drug Resistant Tuberculosis (LiMiT)
NCT00664313Phase 2Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Apr 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linezolid in multidrug-resistant tuberculosis (MDR-TB), Extensively drug-resistant tuberculosis (XDR-TB), sponsored by Centers for Disease Control and Prevention. Started Apr 2009; status: completed.
02
Drugs
linezolid
03
Conditions
multidrug-resistant tuberculosis (MDR-TB)Extensively drug-resistant tuberculosis (XDR-TB)
Beyond the preview
Go deeper on NCT00664313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00664313.